First volunteers inoculated with Malaria human challenge virus
Open Orphan PLC (ORPH.L) Malaria Human Challenge Model Launched
Omega Diagnostics Gp (ODX.L) Directorate Change
Omega (AIM: ODX), the medical diagnostics company focused on Global Health (CD4 and COVID-19) and Health and Nutrition, announces that Colin King, Chief Executive Officer, has notified the Board that
Avacta Group PLC (AVCT.L) Second pre|CISION Pro-drug Candidate Selected
Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary Affimer® and pre|CISION™ platforms announces that the next pre|CISIONTM
TPI provides its latest research note on Midatech Pharma plc (MTPH.L).
Midatech has announced an extension of the Q-Sphera R&D Collaboration (‘the Collaboration’) that was originally detailed on 21 July 2020, while also disclosing that the previously unnamed party is, in
Poolbeg Pharma PLC (POLB.L) Exclusive license of RNA-based immunotherapy asset
Poolbeg Pharma licences first-in-class broad spectrum RNA-based immunotherapy for respiratory virus infections from the University of Warwick
TPI provides its latest research note on DeepVerge plc (DVRG.L)
DeepVerge has released a post-31 December 2021 year-end trading update along with a statement detailing its outlook for the current year.
Evgen Pharma PLC (EVG.L) Progress with UK and US regulators for 2022 trials
Evgen Pharma plc (AIM: EVG), the clinical stage drug development company developing sulforaphane based medicines for the treatment of cancers and inflammation, announces that it has progressed discussions with the
Deepverge PLC (DVRG.L) unaudited 2021 revenue growth exceeds 108% to £9.33m
Skin Trust Club to launch video medical consultations and diagnostic service
TPI provides its latest research note on Microsaic Systems plc (MSYS.L)
Microsaic has provided an unaudited trading update for the year ended 31 December 2021 (‘FY21’).
Genflow Biosciences – Intention to Float on the London Stock Exchange
Genflow Biosciences Plc (“Genflow” or ” the Company”), a UK-based biotechnology company focused on longevity and the development of therapies to counteract the effects of ageing and diseases associated with
Abingdon Health PLC (ABDX.L) Update on AffiDX® SARS-CoV-2 antigen LFT
Technical transfer completed mid-December as planned
